INTRODUCTION
The sulphated glycosaminoglycan (GAG) heparan sulphate (HS) is assembled in the Golgi apparatus by a complex multienzyme machinery. HS chain elongation occurs by addition of alternating -glucuronic acid (GlcA) and N-acetyl--glucosamine (GlcNAc) residues to the priming sugar sequence GlcNAc-GlcA-Gal-GalXyl, which is linked to serine residues of HS proteoglycan core proteins [1, 2] . The modification of the nascent (GlcA-GlcNAc) n polymer is initiated by N-deacetylation and N-sulphation of the GlcNAc units [3] . In HS, this modification occurs in a regioselective manner resulting in the typical domain design of the polysaccharide. The different domain structures include (i) contiguous sequences of N-sulphated disaccharide units (NS domains), (ii) sequences of alternating N-sulphated and N-acetylated disaccharide units and (iii) unmodified sequences with N-acetylated disaccharide units (NA domains). The subsequent modification reactions all occur in the vicinity of previously incorporated N-sulphate groups and include C-5 epimerization of GlcA units into iduronic acid (IdoA) units and O-sulphation at various positions, most commonly at C-2 of the IdoA residues and C-6 of glucosamine (GlcN) units [3] . The co-ordination of the various polymer modification reactions reflects the substrate specificities of the biosynthetic enzymes and possibly their arrangements into complexes. The -glucuronyl C5-epimerase thus requires GlcNSO $ residues for its activity [4] , and the Abbreviations used : BFA, brefeldin A ; HS, heparan sulphate ; MDCK, Madin-Darby canine kidney ; GlcA, D-glucuronic acid ; GlcN, glucosamine ; HexA, hexuronic acid ; IdoA, L-iduronic acid ; GlcNAc, N-acetyl-D-glucosamine ; GAG, glycosaminoglycan ; PAPS, adenosine 3h-phosphate 5h-phosphosulphate ; DMEM, Dulbecco's modified Eagle's medium ; SAX, strong anion exchange ; TGN, trans-Golgi network ; ER, endoplasmic reticulum. 1 To whom correspondence should be addressed (e-mail s.o.kolset!basalmed.uio.no).
turally distinct pools of HS were generated. One pool was similar to HS from control cells, with the exception that the 6-Osulphation of glucosamine (GlcN) residues was reduced. In contrast, the other pool consisted of largely unmodified Nacetylheparosan polymers with a low ( 20 %) proportion of N-sulphated GlcN residues but a substantial proportion of Nunsubstituted GlcN units, indicating that it had been acted upon by N-deacetylases and partly by the N-sulphotransferases, but not by O-sulphotransferases. Together, these findings represent a previously unrecognized alteration in HS biosynthesis caused by BFA, and differ dramatically from our previous findings in MDCK cells pertaining to the undersulphation of HS caused by sodium chlorate treatment.
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IdoA residues formed are 2-O-sulphated more efficiently than GlcA residues [5] . The 6-O-sulphation of GlcN units appears less tightly coupled to GlcNSO $ residues, since these sulphate groups are found both in N-acetylated and N-sulphated disaccharides, which may contain IdoA or GlcA as the hexuronic acid (HexA) component.
Brefeldin A (BFA) is a fungal prostaglandin-like metabolite that has been widely used in studies on the function and organization of the Golgi apparatus. In most cells, treatment with BFA causes fusion of the Golgi cisternae with the endoplasmic reticulum (ER) and separation of these compartments from the trans-Golgi network (TGN), which is more resistant to BFA [6] [7] [8] . Golgi-associated enzymes retain their activity after relocation to the ER, but transport of macromolecules to the TGN and further to the cell surface is inhibited. BFA has therefore been used to differentiate glycosylation processes in the TGN from those occurring in more proximal parts of the Golgi apparatus. Such investigations include studies on the regulation of hyaluronan, chondroitin\dermatan sulphate and HS biosynthesis in various cell types [2, [9] [10] [11] [12] [13] [14] . Studies with ovarian granulosa cells and connective tissue mast cells (which produce heparin instead of HS) indicate that although the secretion of proteoglycans is almost completely inhibited by BFA, sulphated HS\heparin polymers can be recovered from the intracellular fraction, suggesting that the biosynthesis of heparin\HS occurs proximal to the TGN [9, 14] . Notably, however, the HS chains displayed decreased degree of sulphation compared with HS chains from control cells [14] , perhaps reflecting that HS remained inaccessible to sulphotransferases, which might reside in the TGN [15] . Alternatively, the findings might be related to the influence of BFA on cellular sulphation reactions in a more general fashion, for instance, via altered synthesis or Golgi uptake of the high-energy sulphate donor adenosine 3h-phosphate 5h-phosphosulphate (PAPS). BFA has been proposed to inhibit sulphation of galactose and tyrosine residues of secretory proteins [16] .
To understand better the effects of BFA on HS biosynthesis we studied the issue using Madin-Darby canine kidney (MDCK) cells, which differ from most other cell lines in that their Golgi apparatus appears more resistant towards BFA, at least as judged by morphological criteria based on electron microscopic studies [17, 18] . Our previous studies indicate that MDCK cells synthesize predominantly HS proteoglycans, a major proportion of which is secreted to the basolateral culture medium [19] . Moreover, we have characterized in some detail the structural alterations in HS caused by treatment of these cells with sodium chlorate, which inhibits HS sulphation by blocking the formation of PAPS [20] . Structural characterization of secreted HS indicated that BFA promoted the generation of two distinct HS pools. One of the pools displayed the pattern of polymer modification characteristic of HS, but with a lower proportion of 6-Osulphated GlcN residues than in HS from control cells. HS species in the other pool were largely devoid of O-sulphate substituents and had a low degree of N-sulphation but were abundant in N-unsubstituted GlcN residues, indicating that a substantial portion of the GlcNAc residues of the initial polymerization product had undergone N-deacetylation without subsequent N-sulphation.
MATERIALS AND METHODS

Cell culture and labelling
MDCK cells (strain II) were maintained at 37 mC in Dulbecco's modified Eagle's medium (DMEM ; Bio-Whittaker, Verviers, Belgium) supplemented with 5 % fetal calf serum (FCS; Gibco, Paisley, Scotland, U.K.), 2 mM -glutamine, 100 units\ml penicillin and 50 µg\ml streptomycin sulphate. For experiments, cells were seeded on polycarbonate filters (4.7 cm#, pore size 0.4 µm ; Costar, Cambridge, MA, U.S.A.) that were kept in dishes containing culture medium. The cultures reached confluence in 4 days after which the filters were transferred to six-well culture dishes with 1 ml of medium in the apical well and 2 ml of medium in the basolateral well. Metabolic labelling and BFA treatment were carried out in glucose-free DMEM (Gibco) supplemented with 5 % FCS, 2 mM glutamine, 100 µCi\ml [$H]GlcN (Amersham Biosciences, Uppsala, Sweden) and BFA at concentrations indicated in the text and figures. After 24 h, the apical and basolateral media were collected and loose cells pelleted by centrifugation. The media were brought to 4 M guanidine-hydrochloride, 2 % Triton X-100 in 0.1 M sodium acetate, pH 6.0. The cell layers were washed twice with cold phosphate-buffered saline (pH 7.4) before lysis in the guanidinehydrochloride buffer. Labelled macromolecules in the media and cell fractions were separated from free radioactivity using chromatography on 4-ml columns of Sephadex G-50 Fine (Amersham Pharmacia) run in 0.05 M Tris\HCl, pH 8.0, containing 0.15 M NaCl. Proteoglycans were purified by chromatography on a column of DEAE-Sephacel (Pharmacia) eluted with a linear gradient of 0.15-1.5 M NaCl in 0.05 M Tris\HCl, pH 8.0. Proteoglycan fractions were pooled, dialysed against water and finally lyophilized.
Purification of radiolabelled HS
The proteoglycan samples (material derived from six 4.7 cm# cultures of MDCK cells) were treated with 1 unit of chondroitinase ABC (EC 4.2.2.4; Seikagaku Corporation, Tokyo, Japan) in 0.04 M Tris\HCl, pH 7.8\0.04 M sodium acetate containing 0.01 mg\ml BSA for 4 h at 37 mC. HS chains were thereafter liberated from their protein cores by alkaline β-elimination (treatment with 0.5 N NaOH at 4 mC overnight) followed by neutralization of the samples by careful addition of acetic acid. HS chains were recovered by DEAE chromatography as follows : samples were diluted 5-fold with water and passed through a 2-ml column of DEAE-Sephacel equilibrated with 0. 
Depolymerization of HS
Two different chemical depolymerization procedures were employed. First, radiolabelled HS was treated with nitrous acid at pH 1.5 for 10 min at room temperature, after which the pH was increased to $ 9 by addition of Na # CO $ . This treatment causes a near-quantitative cleavage at GlcNSO $ units, whereas GlcNAccontaining disaccharides remain intact [21] . The cleavage products, containing 2,5-anhydromannose units, were reduced with NaBH % to yield terminal anhydromannitol residues. In the second depolymerization procedure, HS was first deacetylated by treatment with hydrazine hydrate [22] (Fluka Chemie AG, Buchs, Switzerland) containing 30 % water and 1 % (w\v) hydrazine sulphate (Merck, Darmstadt, Germany), at 100 mC for 4 h. Hydrazine hydrate was then removed by repeated evaporation to dryness and intermittent addition of water and the samples were desalted by passage through Sephadex PD-10 columns (Pharmacia). Deacetylated HS was treated with nitrous acid at pH 1.5 for 10 min at room temperature, after which the pH was increased to 3.9 (by addition of NaNO $ ) and the treatment continued for 10 min. This treatment causes cleavage at GlcNSO $ units as well as at N-unsubstituted GlcN units, generated by N-deacetylation.
Analysis of HS depolymerization products
To analyse the sizes of the oligosaccharides produced by cleavage of HS with nitrous acid at pH 1.5, the cleavage products were chromatographed on a Bio-Gel P-10 gel filtration column (1i150 cm; Bio-Rad) in 1 M NaCl. Fractions (1 ml) were collected at a flow rate of 3.2 ml\h and analysed for radioactivity. The elution positions of HS oligosaccharides were compared with those of heparin oligosaccharide standards and $&S-labelled HS disaccharides. In order to isolate disaccharides for further compositional analysis, the products from either of the two depolymerization procedures were passed through columns of Sephadex G-15 (1i190 cm) in 0.2 M NH % HCO $ . Fractions corresponding to disaccharides were pooled, dried and subjected to compositional analysis on a Partisil-10 strong anion exchange (SAX) HPLC column (4.6i250 mm, Whatman Inc., Clifton, NJ, U.S.A.). The column-bound disaccharides were eluted with a stepwise gradient of KH # PO % at a flow rate of 1 ml\min. Fractions (1 ml) were collected and counted in a liquid scintillation counter. Disaccharides were identified by comparison with the elution positions of standard heparin disaccharides.
Gel filtration analysis and DEAE chromatography of HS
The hydrodynamic sizes of the HS preparations were compared using gel filtration on a Superose 6 FPLC column (1i30 cm; Pharmacia) run in 1 M NaCl, 0.05 M Tris\HCl, pH 8.0 at a flow rate of 0.5 ml\min using an FPLC pump system. Samples of 20 000 d.p.m. of $H-labelled HS were used for each analysis. Fractions of 0.5 ml were collected and analysed for radioactivity. The void and total volumes of the column were determined using $H-labelled hyaluronan and $H # O, respectively. For analytical DEAE-ion-exchange chromatography, 20 000 d.p.m. of $H-labelled HS was applied to a 2-ml column of DEAE-Sephacel equilibrated with 0.05 M LiCl, 0.05 M sodium acetate, pH 4.0. The column was eluted with a linear gradient of LiCl # ranging from 0.05 to 1.5 M in 0.05 M sodium acetate, pH 4.0. Fractions of 0.5 ml were collected and analysed for radioactivity.
Immunoprecipitations
Medium fractions from MDCK cells labelled with [$H]GlcN with and without BFA, and purified by Sephadex G50 gel chromatography, were incubated with antibodies against perlecan and CD44. Rabbit antiserum against mouse perlecan was a gift from Dr J. R. Hassell (Shriners Hospital, Tampa, FL, U.S.A.) and the mouse monoclonal antibody against human CD44 was given to us by Dr Sirpa Jalkanen (University of Turku, Finland). Following incubation with antibodies, protein A (Amersham Pharmacia) was added. The incubation was continued further and the beads were then washed. HS was released from the beads by alkali treatment, and analysed by MonoQ ion-exchange chromatography as described above for DEAE ion-exchange chromatography.
RESULTS
Effect of BFA on GAG synthesis
MDCK cells were treated with various concentrations of BFA and proteoglycans were recovered by gel filtration and anionexchange chromatography. The incorporation of [$H]GlcN into total GAGs (i.e. the sum of GAG-incorporated radioactivity in the cell and media fractions) in cells treated with BFA was lower than in control cells and the secretion of GAGs decreased with a corresponding accumulation in the cell fraction. After 29 h of radiolabelling, 22 % of the total GAGs in control cells was found in the cell fraction, whereas in BFA-treated cells the proportion was 63 %. In BFA-treated cells, 80 % of the secreted material was recovered from the basolateral medium. Together, these data indicate that although BFA treatment inhibits the synthesis and secretion of GAGs in MDCK cells, a substantial proportion of the GAGs is still secreted to the basolateral medium after a prolonged exposure of cells to BFA. Our further studies were mainly focused on the secreted portion, in which the HS species have traversed all the compartments of the secretory pathway, including the TGN. We have previously [19] shown that MDCK cells synthesize mainly HS proteoglycans and also a significant amount of chondroitin sulphate proteoglycans. The latter have been shown to be secreted predominantly to the apical medium [23] . The low amount of HS recovered from the apical medium after BFA treatment allowed a limited number of analyses only. 
Effect of BFA on polyanionic properties of HS
Metabolically $H-labelled HS was isolated from the basolateral culture media as described in the Materials and methods section. To assess the purity of the isolated [$H]HS from control and BFA-treated cells, samples were treated with HNO # at pH 1.5 and chromatographed on a column of Superose 12 ( Figure 1) . HS from control cells and cells treated with 0.5 µg\ml BFA was quantitatively degraded, whereas HS from cells treated with 2 or 5 µg\ml BFA showed partial degradation. However, these HS species were further degraded by combined treatment with heparitinase and HNO # , pH 1.5, as shown for the sample from cells treated with 5 µg\ml BFA (Figure 1, lower panel) .
Figure 3 Decreased number of N-sulphated saccharide units after BFA treatment of MDCK cells
Samples of [
3 H]HS from control and BFA-treated cells were reacted with HNO 2 followed by reduction of the cleavage products with NaBH 4 . The HS fragments were subjected to gel chromatography on a column of Bio-Gel P10 (1i150 cm). Fractions were collected and analysed for radioactivity. The sizes of the cleavage products are indicated (as number of monosaccharide units) in the top panel.
These data indicate that the HS preparations did not contain contaminating $H-labelled macromolecules. Furthermore, the partial resistance of HS to the deaminative cleavage with HNO # (specific for GlcNSO $ residues at pH 1.5) suggests decreased N-sulphation in cells treated with BFA at the two highest concentrations.
For analysis of the polyanionic properties, samples of [$H]HS were subjected to anion-exchange chromatography on DEAESephacel. HS from control cells was eluted as a single peak at a LiCl # concentration of $ 1.1 M (Figure 2 ), whereas the elution position of HS from cells treated with 0.5 µg\ml BFA was shifted to the left (corresponding to elution at $ 0.9 M LiCl # ) suggesting a decrease in the charge density. Unexpectedly, HS from cells treated with either 2 or 5 µg\ml BFA was eluted as two peaks (Figure 2) , one emerging at a LiCl # concentration of $ 0.6 M and the other close to the elution position of HS from control cells. Thus, treatment of MDCK cells with the two highest concentrations of BFA resulted in two distinct populations of HS with different charge densities. Similar findings were obtained after ion-exchange chromatography of HS from the apical medium of BFA-treated cells (results not shown) indicating that this particular effect of BFA was similar on HS, whether it was secreted to the apical or the basolateral medium. For further analyses, HS species from the basolateral medium corresponding
Figure 4 Increased number of N-unsubstituted GlcN units of HS after BFA treatment of MDCK cells
HS from cells treated with 5 µg/ml BFA was reacted with HNO 2 at pH 3.9, which results in the cleavage of the polymer at N-unsubstituted GlcN residues. Samples of treated and untreated [ 3 H]HS were subjected to gel chromatography on a column of Superose 12. Fractions of 0.5 ml were collected and analysed for radioactivity : #, BFA5; $, BFA5jHNO 2 , pH 3.9.
to the two peaks (denoted as DEAE peaks 1 and 2) were isolated from cells treated with 5 µg\ml BFA and studied separately.
To study whether the occurrence of the two differentially charged HS pools could be related to differences in HS chain length, samples of $H[HS] (including DEAE peaks 1 and 2) were chromatographed on a column of Superose 6. The results indicated that HS chains from BFA-treated MDCK cells were generally slightly longer than those from untreated cells (results not shown), in accordance with earlier observations from ovarian granulosa cells [9] and mastocytoma cells [14] . Furthermore, the chain lengths of DEAE peaks 1 and 2 were essentially similar (results not shown), indicating that the two pools indeed represent two differentially charged HS populations rather than HS with different chain lengths. We also addressed the possibility that the generation of two distinct pools of HS would be due to delayed onset of BFA action, such that material in DEAE peak 2 would be synthesized in the early phase of the BFA treatment. Cells were pretreated with 5 µg\ml BFA up to 20 h, after which they were subjected to a 5-h period of metabolic labelling. Analysis of HS by anion-exchange chromatography revealed two distinct pools of HS (results not shown) similar to those shown in Figure 2 .
Effects of BFA on the N-substitution of HS
The effect of BFA on the N-substitution of HS was studied further by subjecting samples of $H[HS] to HNO # cleavage followed by gel filtration analysis of the cleavage products on a column of Bio-Gel P-10. HS from control cells yielded oligosaccharides ranging between 2 and 20 monosaccharide units in length. The most abundant cleavage products were di-and tetrasaccharides, comprising $ 45 % of total radioactivity, the remainder being evenly distributed between various longer oligosaccharide species (Figure 3) . Using the depolymerization data, an N-sulphation degree of 42 % was calculated for HS from control cells. Treatment of cells with 0.5 µg\ml BFA did not significantly affect the depolymerization pattern. By contrast, HS from cells treated with 2 or 5 µg\ml BFA displayed highly different patterns of depolymerization (Figure 3 ). These HS species yielded a major peak of long, 20-mer oligosaccharides, and lower proportions of short fragments, suggesting markedly decreased N-sulphation. In HS from cells treated with 5 µg\ml BFA, the di-and tetrasaccharides represented only 19 % of the total radioactivity, in marked contrast to the proportion of 42 % found in HS from control cells.
Separate analyses of material corresponding to DEAE peaks 1 and 2 indicated that HS belonging to DEAE peak 2 yielded a similar depolymerization pattern as HS from control cells, and thus had a similar degree of N-sulphation (41 %). In contrast, HS from DEAE peak 1 was largely resistant to HNO # and had an N-sulphation degree of $ 17 %. These data indicate that BFA-treated cells secrete two structurally distinct pools of HS. A major portion of the HS species showed greatly reduced Nsulphation, whereas the other pool appeared to have an unaltered level of N-sulphation. To analyse further the N-substitution of the first pool of HS, material from DEAE peak 1 was subjected to deaminative cleavage by HNO # at pH 3.9 followed by gel
Table 1 Disaccharide composition of N-sulphated domains of HS from BFA-treated and -untreated cells
The values represent the proportions of the various disaccharide species as a percentage of the total disaccharides and are based on the analysis shown in Figure 5 . filtration analysis on a column of Superose 12 (Figure 4) . At this pH, the reagent causes cleavage at N-unsubstituted GlcN units, whereas N-sulphated or N-acetylated GlcN residues remain unaffected [20] . The treatment caused significant depolymerization of HS, indicating a substantial proportion of N-unsubstituted GlcN residues.
Effects of BFA on the O-sulphation of HS
To elucidate further the structural changes in HS as a result of BFA treatment, the disaccharide species derived from the HNO # (pH 1.5) cleavage were analysed by anion-exchange HPLC. Disaccharides from this cleavage represent the internal portions of the NS domains of HS. In control cells, the N-sulphated HS domains were found to be heavily O-sulphated as demonstrated by a large proportion ( 60 %) of trisulphated IdoA(2-OSO $ )-GlcNSO $ (6-OSO $ ) disaccharide units ( Figure 5 , see also Table 1 ). In contrast, the non-O-sulphated HexA-GlcNSO $ disaccharide units represented a minor proportion ($ 5 %) of the total disaccharides ( Figure 5 ). Treatment of cells with BFA resulted in a dose-dependent decrease in the disaccharide species containing 6-O-sulphate [GlcA-GlcNSO $ (6-OSO $ ), IdoA-GlcNSO $ -(6-OSO $ ) and IdoA(2-OSO $ )-GlcNSO $ (6-OSO $ ), corresponding to peaks 2, 3 and 5 in Figure 5 ]. Calculation of the degrees of 2-O-and 6-O-sulphation indicated that whereas the level of 6-Osulphation was decreased almost 60 % by treatment with 5 µg\ml BFA, the degree of 2-O-sulphation was virtually unaffected. These findings indicate a selective effect of BFA on the 6-Osulphation of HS. A similar disaccharide composition was found in a separate analysis of DEAE peak 2 disaccharides, as could be expected because the disaccharides of HS from cells treated with 5 µg\ml BFA originated from DEAE peak 2.
To study further the effects of BFA on the O-sulphation of HS, the samples were subjected to N-deacetylation followed by cleavage with HNO # first at pH 1.5 and then at pH 3.9. This series of treatments leads to complete depolymerization of HS into disaccharides. Analysis of the total disaccharides indicated decreased 6-O-sulphation of GlcN units by BFA treatment (results not shown), in agreement with the results pertaining to disaccharides of the NS domains ( Figure 5) . Notably, compositional analysis of total disaccharides from DEAE peak 1 indicated that the polymers were almost exclusively composed of unsulphated GlcA-GlcN disaccharide units.
Effect of BFA on HS from specific HS proteoglycans
The appearance of two distinct pools of HS in BFA-treated cells might reflect generation of different types of HS on different core proteins of HS proteoglycans. To investigate this possibility, $Hlabelled proteoglycans isolated from the basolateral medium of control and BFA-treated cells were immunoprecipitated with antibodies against the core proteins perlecan and CD44. A proteoglycan form of CD44 is expressed in MDCK cells (K. Fjeldstad, unpublished work). The immunoprecipitated $H-labelled proteoglycans were subjected to alkali treatment to release their HS chains, which were subsequently analysed by anion-exchange chromatography. The elution profiles of HS from perlecan and CD44 were almost identical to that shown in Figure 2 . Hence, the two pools of HS in BFA-treated cells are found in at least two distinct HS proteoglycans, suggesting that their existence is not related to selective effects of BFA on the polymer modification of HS carried by a certain HS proteoglycan core protein.
DISCUSSION
The aim of the present investigation was to gain further understanding into the biosynthesis of HS. Therefore, we used MDCK cells, in which the Golgi complex is morphologically resistant towards BFA. MDCK cells were metabolically labelled with [$H]GlcN and HS proteoglycans were recovered from the basolateral medium for structural characterization. Indeed, in contrast to previous data pertaining to other cell models, we found that BFA-treated MDCK cells secreted HS to the basolateral medium. However, the secreted HS recovered from this fraction was found to contain two distinctly different pools of polysaccharide. One of the pools (DEAE pool 2) displayed all the polymer modifications characteristic of HS, although there was a marked reduction in the 6-O-sulphation of the GlcN units. In contrast, the other pool (DEAE pool 1) contained largely unmodified GlcA-GlcN polymers. The latter pool was virtually devoid of O-sulphate groups, but had been subject to N-deacetylation\ N-sulphation. However, the degree of N-sulphation was lower than in HS from control cells, and the process often remained partial such that N-deacetylation was not followed by Nsulphation, resulting in the generation of N-unsubstituted GlcN residues.
Previous studies with other cell types suggest that BFA would block the biosynthesis of chondroitin sulphate\dermatan sulphate whereas the biosynthesis of HS remains, at least in part, functional under the influence of BFA [9, 10] . However, the secretion of HS proteoglycans is blocked and the HS recovered from the cell fraction appears structurally different from the HS of corresponding cells without BFA treatment [24] . In heparinproducing mouse mastocytoma cells, BFA treatment led to increased heparin chain length but reduced sulphation [14] . The most severely compromised sulphation reaction appeared to be the 2-O-sulphation of IdoA residues, whereas N-and 6-Osulphation of the GlcN units were reduced to a lesser extent. These findings thus differ remarkably from our observations indicating two HS pools with drastically different degrees of sulphation, and further with regard to the effect of BFA on the GlcN 6-O-sulphation but not IdoA 2-O-sulphation. Interestingly, previous studies with ovarian granulosa cells suggest that BFA treatment may give rise to distinct HS pools with either a very low or nearly unaltered degree of sulphation [9] . The Nsulphation of heparan sulphate depends on the bifunctional enzyme N-deacetylase\N-sulphotransferase. The different isoforms have been shown to differ both in their N-deacetylase and N-sulphotransferase activity [25, 26] . Our data could indicate that BFA predominantly inhibited the isoforms with high Nsulphotransferase activity.
The effects of BFA on HS biosynthesis differ markedly from those we have observed previously upon analysis of HS chains obtained from MDCK cells treated with sodium chlorate [20] .
Such MDCK cells expressed HS with a decreased 6-O sulphate content at low chlorate concentrations, and decreased 6-O and 2-O sulphation at higher chlorate concentrations. By contrast, Nsulphation remained essentially unchanged in spite of the chlorate treatment at high concentrations, and there were no indications suggesting the formation of differentially sulphated HS pools. Sodium chlorate inhibits the formation of the high-energy sulphate donor PAPS [27] , and it would therefore provide a tool to study specifically the effects of decreased PAPS levels on HS biosynthesis [28, 29] . Although BFA has been extensively used to study intracellular vesicular transport [7, 8] , and the protein factors that regulate the interactions between different intracellular vesicles, the mechanisms of action of BFA are not understood in detail. BFA inhibits the activation of ADPribosylating factor [30, 31] , which is required for coatomer protein 1 (COP1) to bind membranes [32] . These cytosolic proteins regulate sorting and recycling within Golgi. Recently, BFA was shown to bind to the transitory complex of the nucleotide exchange factor sec7 domain and ADP-ribosylating factor-1 in its GDP-bound state [33] . Furthermore, cells resistant to BFA treatment [6, 17] have been proposed to contain a so far unidentified ' resistance factor ' [34] .
In addition to effects on GAG biosynthesis, BFA has been shown to influence other biosynthetic pathways involving protein glycosylation. In several cell types, BFA has been reported to inhibit sialylation of N-linked, but not O-linked, membrane glycoproteins [35] . However, in melanoma cells, where the proteoglycans studied also carry N-linked oligosaccharides, BFA treatment did not affect sialylation of the oligosaccharide part of the molecules [11] . Consequently, the effects of BFA on protein glycosylation differ depending on the cell type studied.
BFA may interfere with mobility and organization of glycosyltransferases in Golgi cisternae. The results reported here suggest that, in MDCK cells, BFA treatment leads to a separation of the HS polymerization and subsequent polymer modifications, most conspicuously with regard to O-sulphation. In addition, in the Osulphated pool of HS the 2-O-and 6-O-sulphation reactions were differently influenced by BFA such that 6-O-sulphation was decreased whereas 2-O-sulphation remained virtually unaltered. These findings might be explained by different Golgi localization of the two sulphotransferase activities because the 6-Osulphation of GlcN residues is thought to be a later step of HS biosynthesis than 2-O-sulphation of IdoA. A more detailed molecular understanding of the effects of BFA, both in resistant and non-resistant cells, should provide further insight into the mechanisms regulating the enzymes involved in HS polymerization and modifications.
